Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebido for Hypogonadism and Erectile Dysfunction
NCT00421460Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- Jan 2007
- Primary completion
- Jan 2011
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, open-label trial of testosterone undecanoate in Hypogonadism and erectile dysfunction (ED), sponsored by Chulalongkorn University. Primary endpoint: International Index of Erectile Function-5 at 46 weeks. Started Jan 2007; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadismerectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00421460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421460.